Literature DB >> 19656901

Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.

Wenji Piao1, Chang Song, Haiyan Chen, Marco A Quevedo Diaz, Larry M Wahl, Katherine A Fitzgerald, Liwu Li, Andrei E Medvedev.   

Abstract

Endotoxin tolerance reprograms cell responses to LPS by repressing expression of proinflammatory cytokines, while not inhibiting production of anti-inflammatory cytokines and antimicrobial effectors. Molecular mechanisms of induction and maintenance of endotoxin tolerance are incompletely understood, particularly with regard to the impact of endotoxin tolerization on signalosome assembly, activation of adaptor-kinase modules, and expression of negative regulators of TLR signaling in human cells. In this study, we examined LPS-mediated activation of MyD88-dependent and Toll-IL-1R-containing adaptor inducing IFN-beta (TRIF)-dependent pathways emanating from TLR4 and expression of negative regulators of TLR signaling in control and endotoxin-tolerant human monocytes. Endotoxin tolerization suppressed LPS-inducible TLR4-TRIF and TRIF-TANK binding kinase (TBK)1 associations, induction of TBK1 kinase activity, activation of IFN regulatory factor (IRF)-3, and expression of RANTES and IFN-beta. Tolerance-mediated dysregulation of the TLR4-TRIF-TBK1 signaling module was accompanied by increased levels of suppressor of IkappaB kinase-epsilon (SIKE) and sterile alpha and Armadillo motif-containing molecule (SARM). LPS-tolerant cells showed increased expression of negative regulators Toll-interacting protein (Tollip), suppressor of cytokine signaling (SOCS)-1, IL-1R-associated kinase-M, and SHIP-1, which correlated with reduced p38 phosphorylation, IkappaB-alpha degradation, and inhibited expression of TNF-alpha, IL-6, and IL-8. To examine functional consequences of increased expression of Tollip in LPS-tolerized cells, we overexpressed Tollip in 293/TLR4/MD-2 transfectants and observed blunted LPS-inducible activation of NF-kappaB and RANTES, while TNF-alpha responses were not affected. These data demonstrate dysregulation of TLR4-triggered MyD88- and TRIF-dependent signaling pathways and increased expression of negative regulators of TLR signaling in endotoxin-tolerant human monocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656901      PMCID: PMC2796624          DOI: 10.1189/jlb.0309189

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  75 in total

1.  Gene-specific control of inflammation by TLR-induced chromatin modifications.

Authors:  Simmie L Foster; Diana C Hargreaves; Ruslan Medzhitov
Journal:  Nature       Date:  2007-05-30       Impact factor: 49.962

Review 2.  How important are Toll-like receptors for antimicrobial responses?

Authors:  Susan Carpenter; Luke A J O'Neill
Journal:  Cell Microbiol       Date:  2007-05-23       Impact factor: 3.715

Review 3.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

Review 4.  Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins.

Authors:  Alexander Dalpke; Klaus Heeg; Holger Bartz; Andrea Baetz
Journal:  Immunobiology       Date:  2007-11-28       Impact factor: 3.144

5.  Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.

Authors:  Tatsukata Kawagoe; Shintaro Sato; Kazufumi Matsushita; Hiroki Kato; Kosuke Matsui; Yutaro Kumagai; Tatsuya Saitoh; Taro Kawai; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2008-04-27       Impact factor: 25.606

6.  Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance.

Authors:  Subhra K Biswas; Pradeep Bist; Manprit Kaur Dhillon; Tasneem Kajiji; Carlos Del Fresno; Masahiro Yamamoto; Eduardo Lopez-Collazo; Shizuo Akira; Vinay Tergaonkar
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

7.  Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance.

Authors:  Wenji Piao; Chang Song; Haiyan Chen; Larry M Wahl; Katherine A Fitzgerald; Luke A O'Neill; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

8.  Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes.

Authors:  Fumiyo Ikeda; Christina Maria Hecker; Alexis Rozenknop; Rolf Dietrich Nordmeier; Vladimir Rogov; Kay Hofmann; Shizuo Akira; Volker Dötsch; Ivan Dikic
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

9.  Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Barbara K Yoza; Jean Y-Q Hu; Sue L Cousart; Charles E McCall
Journal:  J Biol Chem       Date:  2007-07-23       Impact factor: 5.157

10.  The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.

Authors:  Zachary J Roberts; Nadege Goutagny; Pin-Yu Perera; Hiroki Kato; Himanshu Kumar; Taro Kawai; Shizuo Akira; Ram Savan; David van Echo; Katherine A Fitzgerald; Howard A Young; Lai-Ming Ching; Stefanie N Vogel
Journal:  J Exp Med       Date:  2007-06-11       Impact factor: 14.307

View more
  63 in total

1.  Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.

Authors:  Michael B Murphy; Yanbao Xiong; Goutham Pattabiraman; Tissa T Manavalan; Fu Qiu; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2015-08-26       Impact factor: 4.962

Review 2.  The unfolding web of innate immune dysregulation in alcoholic liver injury.

Authors:  G Szabo; P Mandrekar; J Petrasek; D Catalano
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

3.  IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling.

Authors:  Janice Chen; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.

Authors:  Yanbao Xiong; Meghan Pennini; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2013-05-21       Impact factor: 4.962

5.  Burkholderia pseudomallei-induced expression of a negative regulator, sterile-alpha and Armadillo motif-containing protein, in mouse macrophages: a possible mechanism for suppression of the MyD88-independent pathway.

Authors:  M Pudla; K Limposuwan; P Utaisincharoen
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

6.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

7.  Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization.

Authors:  Xianjing Li; Zhuo Wang; Yulian Zou; Ermei Lu; Jingjing Duan; Hongbao Yang; Qijin Wu; Xiaona Zhao; Yun Wang; Linjun You; Ling He; Tao Xi; Yong Yang
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

8.  Alteration of lysosome fusion and low-grade inflammation mediated by super-low-dose endotoxin.

Authors:  Bianca Baker; Shuo Geng; Keqiang Chen; Na Diao; Ruoxi Yuan; Xiguang Xu; Sean Dougherty; Caroline Stephenson; Huabao Xiong; Hong Wei Chu; Liwu Li
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

9.  Lrg participates in lipopolysaccharide preconditioning-induced brain ischemia injury via TLR4 signaling pathway.

Authors:  Gu Gong; Shurong Bai; Wei Wu; Ling Hu; Yinghai Liu; Jie Niu; Xuemei Dai; Liang Yin; Xiaowu Wang
Journal:  J Mol Neurosci       Date:  2014-02-15       Impact factor: 3.444

10.  Toll-like receptors in the pathogenesis of alcoholic liver disease.

Authors:  Jan Petrasek; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Gastroenterol Res Pract       Date:  2010-08-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.